Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha Baskaran

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Drug Safety|June 23, 2025
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practiceeGilmar Gutierrez, Gustavo Vazquez, Nisha Ravindran, et al.
Journal of Affective Disorders|October 9, 2025
Beyond symptom scales: Patient-centered insights into deep brain stimulation outcomes in treatment-refractory post-traumatic stress disorderIsabella J Sewell, Rohina Kumar, Alexander J Nyman, et al.
Molecular Psychiatry|May 15, 2020
Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trialsBenjamin Davidson, Clement Hamani, Jennifer S Rabin, et al.
Psychiatry Research|August 11, 2024
IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depressionGilmar Gutierrez, Jennifer Swainson, Nisha Ravindran, et al.
Molecular Psychiatry|July 20, 2022
Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trialBenjamin Davidson, Peter Giacobbe, Tony P George, et al.
Biological Psychiatry|August 26, 2024
Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive DisorderClement Hamani, Benjamin Davidson, Jennifer S Rabin, et al.
Bipolar Disorders|December 17, 2013
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorderRoger S McIntyre, Danielle S Cha, Jeanette M Jerrell, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disordersDanielle S Cha, Francesco De Michele, Joanna K Soczynska, et al.
Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Drug Safety|June 23, 2025
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practiceeGilmar Gutierrez, Gustavo Vazquez, Nisha Ravindran, et al.
Journal of Affective Disorders|October 9, 2025
Beyond symptom scales: Patient-centered insights into deep brain stimulation outcomes in treatment-refractory post-traumatic stress disorderIsabella J Sewell, Rohina Kumar, Alexander J Nyman, et al.
Molecular Psychiatry|May 15, 2020
Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trialsBenjamin Davidson, Clement Hamani, Jennifer S Rabin, et al.
Psychiatry Research|August 11, 2024
IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depressionGilmar Gutierrez, Jennifer Swainson, Nisha Ravindran, et al.
Molecular Psychiatry|July 20, 2022
Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trialBenjamin Davidson, Peter Giacobbe, Tony P George, et al.
Biological Psychiatry|August 26, 2024
Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive DisorderClement Hamani, Benjamin Davidson, Jennifer S Rabin, et al.
Bipolar Disorders|December 17, 2013
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorderRoger S McIntyre, Danielle S Cha, Jeanette M Jerrell, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disordersDanielle S Cha, Francesco De Michele, Joanna K Soczynska, et al.
Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Pageof 2